NUCLIDIUM AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, has closed its Series B financing round led by Kurma Growth Opportunities Fun...
Read More
Our CEO, Joanne Sieber, recently sat down with the influential Swiss newspaper Le Temps to discuss a critical challenge for the nation’s future: financing the growth of our most promising deep tec...
Read More
Stefan Kyora startupticker.ch The first Swiss Deep Tech Report presents data-driven evidence of the advantages that make Switzerland a global deep tech hotspot. It also provides a...
Read More
This mid-year reading of startupticker.ch and SECA’s Swiss VC Report takes the surface rebound—a healthy rise in invested capital—and weighs it against quieter signals: fewer deals overall, a fund...
Read More